CTRI Number |
CTRI/2010/091/001054 [Registered on: 08/07/2010] |
Last Modified On: |
|
Post Graduate Thesis |
|
Type of Trial |
|
Type of Study
|
|
Study Design |
Single Arm Study |
Public Title of Study
|
A study of Condom catheter balloon to control excessive bleeding after childbirth. |
Scientific Title of Study
|
Evaluation of Uterine tamponade using condom catheter balloon in management of nontraumatic postpartum hemorrhage |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DR Asmita Muthal Rathore |
Designation |
|
Affiliation |
|
Address |
217, DG III Vikaspuri New Delhi DELHI 110018 India |
Phone |
011 28531848 |
Fax |
|
Email |
asmita.rathore@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
DR Asmita Muthal Rathore |
Designation |
|
Affiliation |
Maulana Azad Medical College, New Delhi |
Address |
217, DG III Vikaspuri New Delhi DELHI 110018 India |
Phone |
011 28531848 |
Fax |
|
Email |
asmita.rathore@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Sonali Gupta |
Designation |
|
Affiliation |
|
Address |
C-1/4A yamuna Vihar
New Delhi DELHI 110054 India |
Phone |
011 22914305 |
Fax |
|
Email |
sonali_2706@yahoo.co.in |
|
Source of Monetary or Material Support
|
Department of obstetrics and gynecology, Maulana Azad Medical College, New Delhi |
|
Primary Sponsor
|
Name |
nil |
Address |
|
Type of Sponsor |
|
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr A M Rathore |
Department of obstetrics and gynecology, Maulana Azad Medical College, NewDelhi |
,-
|
09968604345
asmita.rathore@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee, Maulana Azad Medical College, New Delhi |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
postpartum hemorrhage, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
nil |
|
Intervention |
uterine tamponade with condom catheter balloon |
8-48 hours |
|
Inclusion Criteria
|
Age From |
|
Age To |
|
Gender |
|
Details |
Post partum hemorrhage not responding to medical management (appropriate doses of oxytocics and prostaglandins) |
|
ExclusionCriteria |
Details |
1. Bleeding due to genital tract trauma and retained placental tissue
2. Known allergy to latex
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Time required to stop bleeding after tamponade is applied |
control of hemorrhage |
|
Secondary Outcome
|
Outcome |
TimePoints |
Need for additional surgical measures eg devascularization ,B Lynch, hysterectomy |
unstable hemodynamic status of mother |
|
Target Sample Size
|
Total Sample Size="15" Sample Size from India=""
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
Date Missing |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
12/10/2009 |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Open to Recruitment |
Recruitment Status of Trial (India) |
|
Publication Details
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
tamponade created at predefined point. Primary outcomes noted. If successful, tamponade continued for 8-48 hours with defined monitoring. Tamponade removed after criterias fulfilled. Secondary outcomes noted. |